Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MRI in thorotrastosis

N Ono1, K Hirai, H Ijyuin

  • 1Second Department of Medicine, Kurume University School of Medicine, Japan.

Clinical Imaging
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stimulation of the hamster ventral lateral geniculate nucleus induces Fos-like immunoreactivity in suprachiasmatic nucleus cells.

Neuroscience letters·1992
Same author

Papillary craniopharyngioma of the third ventricle--case report.

Neurologia medico-chirurgica·1992
Same author

Sequential change of heterogeneous cerebral blood blow patterns after diffuse brain ischemia.

Resuscitation·1992
Same author

Cerebral infarction in a heterozygote with variant antithrombin III.

Stroke·1992
Same author

Ocular convergence-related neuronal responses in the lateral suprasylvian area of alert cats.

Neuroscience research·1992
Same author

[Evaluation of cerebral blood circulation using fast magnetic resonance imaging (turbo-FLASH)].

No shinkei geka. Neurological surgery·1992

Computed tomography (CT) detects Thorotrast deposition in thorotrastosis patients, while MRI does not. MRI may aid early detection of tumors, a complication of Thorotrast exposure.

Area of Science:

  • Radiology
  • Medical Imaging
  • Nuclear Medicine

Background:

  • Thorotrast (thorium dioxide) is a radioactive contrast agent historically used for medical imaging.
  • Thorotrast administration can lead to long-term deposition in organs like the liver and spleen, posing a risk for malignancy.
  • Evaluating imaging modalities for detecting Thorotrast deposition and its complications is crucial.

Purpose of the Study:

  • To compare the effectiveness of CT and MRI in visualizing Thorotrast deposition in patients with thorotrastosis.
  • To assess the impact of Thorotrast deposition on spleen morphology and MRI characteristics.
  • To determine the potential utility of MRI in the early detection of malignant tumors in thorotrastosis patients.

Main Methods:

  • Four patients with a history of Thorotrast exposure underwent both CT and MRI scans.

Related Experiment Videos

  • Image analysis focused on identifying Thorotrast deposits, evaluating splenic volume and atrophy, and measuring contrast-noise ratio on T1-weighted MRI sequences.

    • Main Results:

    • CT scans clearly showed high-density Thorotrast deposits in the liver, spleen, and abdominal lymph nodes.
    • These Thorotrast deposits were not visualized on MRI scans.
    • Patients exhibited significantly reduced splenic volume due to atrophy, and a lower contrast-noise ratio in the spleen on T1-weighted MRI.
    • Thorotrast deposition did not alter the overall MRI appearance of the organs.

    Conclusions:

    • CT is effective in identifying Thorotrast deposition, while MRI does not directly visualize these deposits.
    • MRI may be a valuable tool for the early detection of malignant tumors, a known complication of thorotrastosis, due to its ability to assess organ changes without being affected by Thorotrast presence.